Free Trial

Alector (ALEC) Competitors

Alector logo
$3.21 -0.10 (-3.02%)
Closing price 10/21/2025 04:00 PM Eastern
Extended Trading
$1.60 -1.62 (-50.31%)
As of 08:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ALEC vs. TRML, NBTX, MAZE, ARDX, CVAC, IMTX, SANA, PGEN, CALT, and NUVB

Should you be buying Alector stock or one of its competitors? The main competitors of Alector include Tourmaline Bio (TRML), Nanobiotix (NBTX), Maze Therapeutics (MAZE), Ardelyx (ARDX), CureVac (CVAC), Immatics (IMTX), Sana Biotechnology (SANA), Precigen (PGEN), Calliditas Therapeutics AB (publ) (CALT), and Nuvation Bio (NUVB). These companies are all part of the "pharmaceutical products" industry.

Alector vs. Its Competitors

Alector (NASDAQ:ALEC) and Tourmaline Bio (NASDAQ:TRML) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

In the previous week, Alector had 12 more articles in the media than Tourmaline Bio. MarketBeat recorded 14 mentions for Alector and 2 mentions for Tourmaline Bio. Tourmaline Bio's average media sentiment score of 1.47 beat Alector's score of -0.19 indicating that Tourmaline Bio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alector
1 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Neutral
Tourmaline Bio
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tourmaline Bio has lower revenue, but higher earnings than Alector. Tourmaline Bio is trading at a lower price-to-earnings ratio than Alector, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alector$100.56M3.23-$119.05M-$1.16-2.77
Tourmaline BioN/AN/A-$73.21M-$3.43-13.97

Alector has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, Tourmaline Bio has a beta of 2.27, meaning that its share price is 127% more volatile than the S&P 500.

Tourmaline Bio has a net margin of 0.00% compared to Alector's net margin of -142.10%. Tourmaline Bio's return on equity of -30.50% beat Alector's return on equity.

Company Net Margins Return on Equity Return on Assets
Alector-142.10% -112.06% -26.37%
Tourmaline Bio N/A -30.50%-29.63%

Alector presently has a consensus price target of $3.83, indicating a potential upside of 19.42%. Tourmaline Bio has a consensus price target of $45.65, indicating a potential downside of 4.72%. Given Alector's higher possible upside, equities research analysts plainly believe Alector is more favorable than Tourmaline Bio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alector
3 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.82
Tourmaline Bio
1 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

85.8% of Alector shares are owned by institutional investors. Comparatively, 91.9% of Tourmaline Bio shares are owned by institutional investors. 9.7% of Alector shares are owned by company insiders. Comparatively, 13.0% of Tourmaline Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Tourmaline Bio beats Alector on 8 of the 14 factors compared between the two stocks.

Get Alector News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALEC vs. The Competition

MetricAlectorMED IndustryMedical SectorNASDAQ Exchange
Market Cap$335.01M$3.47B$6.23B$10.67B
Dividend YieldN/A2.27%5.74%4.88%
P/E Ratio-2.7723.0629.1527.23
Price / Sales3.23497.06588.88131.98
Price / CashN/A47.5937.5161.65
Price / Book2.4910.6612.326.59
Net Income-$119.05M-$52.56M$3.32B$276.14M
7 Day Performance0.63%2.64%0.73%-0.72%
1 Month Performance0.94%13.86%7.27%2.47%
1 Year Performance-31.70%14.85%61.92%33.90%

Alector Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALEC
Alector
3.9427 of 5 stars
$3.21
-3.0%
$3.83
+19.4%
-30.4%$335.01M$100.56M-2.77270Trending News
Analyst Downgrade
Gap Down
High Trading Volume
TRML
Tourmaline Bio
1.6768 of 5 stars
$47.90
flat
$45.65
-4.7%
+69.3%$1.23BN/A-13.9644Positive News
Short Interest ↓
NBTX
Nanobiotix
0.8494 of 5 stars
$25.60
-3.7%
$11.00
-57.0%
+370.3%$1.23B$39.18M0.00100Gap Down
High Trading Volume
MAZE
Maze Therapeutics
2.3716 of 5 stars
$27.81
-2.2%
$33.83
+21.7%
N/A$1.22B$167.50M0.00121Short Interest ↑
ARDX
Ardelyx
4.2839 of 5 stars
$5.03
-0.4%
$11.70
+132.6%
-10.0%$1.21B$333.61M-21.8790
CVAC
CureVac
3.5299 of 5 stars
$5.36
-0.2%
$6.83
+27.5%
+93.9%$1.20B$579.18M5.58880
IMTX
Immatics
2.9453 of 5 stars
$9.87
-3.2%
$13.67
+38.5%
+9.5%$1.20B$168.65M-15.18260
SANA
Sana Biotechnology
2.8289 of 5 stars
$5.03
-5.1%
$7.50
+49.1%
+45.3%$1.20BN/A-4.75380
PGEN
Precigen
4.291 of 5 stars
$4.00
+14.6%
$8.25
+106.3%
+340.0%$1.19B$3.92M-9.52190High Trading Volume
CALT
Calliditas Therapeutics AB (publ)
N/A$40.00
flat
N/AN/A$1.19B$1.60B-21.62180
NUVB
Nuvation Bio
2.2701 of 5 stars
$3.41
-6.1%
$7.86
+130.4%
+78.2%$1.17B$7.87M-5.4160

Related Companies and Tools


This page (NASDAQ:ALEC) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners